Lymphoma Associated studies

Open trials

Short name ZUMA-2 cohort 3
Study title A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-X19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2)
Status Open in AUMC (AMC), EMC & UMCG
Medication KTE-X19
Population r/r MCL BTKi-naive (i.e. Ibrutinib, Acalabrutinib)
Study docs Subject eligibility
Short name HD21
Study title Treatment optimization trial in the first line treatment of adv stage HL: comparison of 4-6 cycles of esc BEACOPP with 4-6 cycles of BrECADD
Status Open
Participants AmsterdamUMC - VUmc- JM Zijlstra
MeanderMC – JC Regelink
Jeroen Bosch ziekenhuis- H Pruijt
ADR ziekenhuis Goes- S Kuipers
OLVG A’dam – A. Gerrits
WFG Hoorn- C Klerk
Haga ziekenhuis- L Bohmer
LUMC- H Veelken
Anthonius ziekenhuis- M Sohne
Study docs Flow + eligibility
Protocol

 

Up